Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicityYasmina Mozo, Beatriz Ruz-Caracuel, Blanca Rosich et al.|Pediatric Hematology and Oncology|2021Cited by 28
Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)Víctor Galán‐Gómez, Antonio Pérez‐Martínez, Cristina Beléndez et al.|Transplantation and Cellular Therapy|2023Cited by 1